Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(20.35%) (26.03%) (28.69%) (21.85%)

+8 more TTM periods

Piotroski F-Score
6 6 5 4
ROA
(6.02%) (7.66%) (8.38%) (6.43%)
ROIC
(30.17%) (32.27%) (27.84%) (18.39%)
Return on Tangible Assets
(63.31%) (91.61%) (117.31%) (94.58%)
Average Days of Receivables
32.51 35.79 33.93 45.38
Free Cash Flow per Share
18.13 14.45 8.76 6.83
Free Cash Flow
8,951.00 7,112.00 4,321.00 3,356.00
Capital Expenditures
(798.00) (832.00) (767.00) (708.00)
Other line items
Cash ROIC
13.60% 11.54% 7.48% 5.80%
Accounts Receivable Turnover
10.24 9.46 10.30 8.98
Accounts Payable Turnover
11.88 11.95 13.42 11.30
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
35.05 33.41 27.83 36.08
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.10 0.01 (0.01) 0.09
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
6.41% 6.54% 6.63% 6.87%
Share Based Compensation of Revenue
0.12% 0.11% 0.10% 0.10%
Interest Coverage
(8.61) (10.86) (11.24) (8.36)
Operating CF/Net income
(1.91) (1.23) (0.76) (0.77)
Depreciation/Fixed assets
0.59 0.60 0.63 0.58
Capex/Depreciation
(0.64) (0.66) (0.60) (0.56)
Revenue per Share
410.96 402.59 394.99 378.42
Operating CF per Share
19.74 16.14 10.32 8.27
Capex per Share
(1.62) (1.69) (1.56) (1.44)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates